Regeneron and its partner Sanofi announced positive results in the first trial of their extensive Phase III ODYSSEY program (12 trials in total) for alirocumab (REGN-727), which targets PCSK9 to lower LDL (or “bad”) cholesterol. Alirocumab showed a 47.2% reduction in LDL levels from baseline over 24 weeks in patients with primary hypercholesterolemia and moderate…
Facebook Inc (NASDAQ FB) is receiving an increasing chunk of brand marketing, especially when it comes to posting and playing videos, says a report from Ad Week. Brands such as Budweiser and McDonald’s and celebrities such as Beyonce are now posting videos directly to the social network instead of just posting YouTube links. YouTube was…
I always love to talk about personal finance with my friends and family. And as a wise man once told me 😉, “Personal finance is like a box of chocolates; you never know what you’re going to get.” But recently, the same word keeps coming up repeatedly: “inflation”… A compelling fact is that my $100…
ResMed delivered another impressive performance in the third quarter of fiscal 2013. Revenue rose 10% to USD 384 million, operating income increased 26% to USD 96.1 million and net income was 31% higher at USD 84.9 million. Diluted earnings per share rose 32% to USD 0.58 and over the nine months to 31 March 2013…
PNC Financial Services Group reported net income of $1.1 billion, or $1.99 per diluted share, for second quarter 2013 compared with $1.0 billion or $1.76 per diluted share for first quarter 2013. There were some one-time items, including securities gains ($61 million), gains on sale of Visa V stock ($83 million), and lower loss provision…
Boart Longyear announced a disappointing first-half 2013 result, incurring an operating net loss after tax, or NPAT of USD 60 million, after reporting a profit of USD 98 million in first-half 2012. In addition, Boart incurred USD 269 million of post tax, mainly non-cash restructuring charges and asset impairments. The result reflected a weak operating…
